Institutional Ownership Cyma Bay Therapeutics, Inc. (CBAY)
This table provides information about the institutional ownership of Cyma Bay Therapeutics, Inc. (CBAY). We have compiled data on the 7 institutions that hold shares in the stock, with a total of 1.82 Million shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Foresite Capital Management Iii, LLC
Larkspur, CA |
Nov 14, 2022 Q3 2022 |
1,641,804
shares
|
$0
15.17% of portfolio
|
Q3 2020
Added 2.62%
|
|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
131,036
shares
|
$0
0.27% of portfolio
|
Q4 2018
Reduced 52.07%
|
|
|
Connacht Asset Management LP
New York, NY |
Nov 14, 2023 Q3 2023 |
11,986
shares
|
$0
1.09% of portfolio
|
Q3 2023
Reduced 65.29%
|
|
|
Ctc Capital Management, LLC
|
May 05, 2023 Q1 2023 |
10,700
shares
|
$0
0.2% of portfolio
|
Q1 2023
New holding
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
10,641
shares
|
$0
0.0% of portfolio
|
Q2 2023
Reduced 32.25%
|
|
|
First Republic Investment Management, Inc.
San Francisco, CA |
Nov 07, 2023 Q3 2023 |
10,627
shares
|
$0
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
Able Wealth Management LLC
Lakewood, NJ |
Feb 20, 2024 Q4 2023 |
83
shares
|
$0
0.0% of portfolio
|
Q4 2023
New holding
|